Why So Few Women Bioscientists at the Podium?

If visual impact correctly represented the position and participation of women in the biosciences, we could all join the Hallelujah Chorus and say the battle for recognition of women has been won and that further efforts could be laid to rest. Yes, it is true that more women have obtained junior staff appointments and that a few have even obtained senior appointments, more so than would have happened 10 years ago. But can one really say that women are hired in proportion to their numbers and acc

Written byRose Johnstone
| 4 min read

Register for free to listen to this article
Listen with Speechify
0:00
4:00
Share

A quick—and far from precise—nose count at the International Congress of Biochemistry in Amsterdam in August 1985 showed that 20 percent of the participants were women. But while many women presented posters or were major research contributors to the work reported at the addresses, they were conspicuous by their absence in the major symposia and the mini-symposia.

We recently did a nose count of women authors in two randomly chosen issues each of two leading journals in the biosciences— the Journal of Biological Chemistry and the Journal of Cell Biology— both of which list the author's first name. Female names made up 19 percent (57 out of 300) and 18 percent (48 out of 280), respectively, of the authors' names. These figures agree remarkably well with the attendance of women at the International Congress.

Curiously, the magic 20 percent also agrees with attendance at the 1986 summer meeting of the ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

Published In

Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies